AARTISURF vs NOCIL: Stock Comparison

AARTISURF vs NOCILUpdated 14 Aug 26, 4:08 PM ISTNSE & company filings

NOCIL is the larger company by market capitalisation. AARTISURF shows a lower P/E, a higher ROE and faster revenue growth, while NOCIL shows a higher dividend yield, lower leverage and a higher net margin. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

AARTISURF leads 6; NOCIL leads 6 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

AARTISURFNOCIL

Valuation lens

What price are you paying?

Market CapContext only
₹431 Cr
₹3,163 Cr
P/E RatioAARTISURF has the lower reading
28.84x
47.82x
P/B RatioNOCIL has the lower reading
2.17x
1.78x
EPSAARTISURF has the higher reading
₹10.63
₹1.64
Book ValueContext only
₹289.14
₹106.18
Dividend YieldNOCIL has the higher reading
0.2%
0.79%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
NOCIL is the larger company
₹3,163 Cr vs ₹431 Cr
P/E Ratio
AARTISURF has a lower P/E
28.84x vs 47.82x
P/B Ratio
NOCIL has a lower P/B
1.78x vs 2.17x
EPS
AARTISURF has higher earnings per share
₹10.63 vs ₹1.64
Dividend Yield
NOCIL has a higher dividend yield
0.79% vs 0.2%
Revenue Growth (TTM YoY)
AARTISURF has faster revenue growth
26.8% vs -2.8%
EPS Growth (TTM YoY)
NOCIL has faster EPS growth
-19.2% vs -57%
Qtr Profit Growth
AARTISURF has stronger quarterly profit growth
-0.84% vs -1.59%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricAARTISURFNOCIL
SectorChemicalsChemicals
IndustrySpecialty ChemicalsSpecialty Chemicals

Price

MetricAARTISURFNOCIL
Live Price₹658.55₹189.65
Day Change1.97%-2.9%
Volume1.04 L12.03 L
52-Week High₹677.7₹204.5
52-Week Low₹316₹125.31
Distance from 52W High-2.83%-7.26%

Valuation

MetricAARTISURFNOCIL
Market Cap₹431 Cr₹3,163 Cr
P/E Ratio28.84x47.82x
P/B Ratio2.17x1.78x
EPS₹10.63₹1.64
Book Value₹289.14₹106.18
Dividend Yield0.2%0.79%

Growth

MetricAARTISURFNOCIL
Revenue Growth (TTM YoY)26.8%-2.8%
EPS Growth (TTM YoY)-57%-19.2%
Qtr Sales Growth0%0%
Qtr Profit Growth-0.84%-1.59%

Profitability & Leverage

MetricAARTISURFNOCIL
ROE5.14%3.61%
ROCE6.33%4.04%
Net Margin1.44%4.86%
Operating Margin3.48%6.54%
Debt to Equity0.42x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricAARTISURFNOCIL
Promoter Holding49.63% 0.03 pp33.76%
FII Holding0.08% 0.06 pp4.78% 0.23 pp
DII Holding0%7.47% 0.44 pp
Public Holding50.07% 0.09 pp53.98% 0.2 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: AARTISURF and NOCIL.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.